It achieves AI-driven generative design of the first permeable macrocyclic peptide with more than two polar or ionizable fragments. -- Surrogate assays are a breakthrough for AI model training. 1910 ...
PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...
SHIRLEY, NY, USA, July 1, 2024 /EINPresswire.com/ -- As a leading provider of innovative drug development services, Creative Bioarray is pleased to announce the ...
The CellTiter-Glo ® 2.0 Cell Viability Assay is a luminescent method for swift, convenient, routine cell viability assessments. Offers equivalent performance to the classic CellTiter-Glo ® Cell ...
11d
1910 Publishes PEGASUS™, a Multimodal AI Model that Engineers Novel Drug-Like Macrocyclic Peptides
BOSTON, January 06, 2026--1910, the only AI-native biotech pioneering small and large molecule therapeutics discovery, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback